Development of a human papillomavirus competitive luminex immunoassay for 9 HPV types

In the clinical trials of the quadrivalent human papillomavirus (qHPV) vaccine, antibodies were measured by a competitive Luminex immunoassay (HPV-4 cLIA). A nine-valent HPV (9vHPV) vaccine targeting the types in the qHPV vaccine (HPV6/11/16/18), as well as 5 of the next most frequent HPV types foun...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Hum Vaccin Immunother
Главные авторы: Roberts, Christine, Green, Tina, Hess, Erica, Matys, Katie, Brown, Martha J, Haupt, Richard M, Luxembourg, Alain, Vuocolo, Scott, Saah, Alfred, Antonello, Joseph
Формат: Artigo
Язык:Inglês
Опубликовано: Taylor & Francis 2014
Предметы:
Short Report
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4896759/
https://ncbi.nlm.nih.gov/pubmed/25424920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.29205
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы